CULLINAN

What this means for you

Registered since 20 May 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97778211

Registration number

7797946

Mark type

Stylized text

Filed

02 Feb 2023

Published for opposition

01 Apr 2025

Registered

20 May 2025

Attorney of record

Malaika D. Tyson

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer; therapeutic pharmaceuticals for the treatment of cancer; anti-cancer preparations being anti-cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer and for use in the fields of oncology and immunology
• Class 042 — Scientific and technological services: Pharmaceutical research and development; scientific research and development; medical research and development; medical research and development services in the fields of drug discovery and oncology

Owner

• CULLINAN THERAPEUTICS, INC., CAMBRIDGE, MA, US
• CULLINAN THERAPEUTICS, INC., CAMBRIDGE, MA, US
• CULLINAN THERAPEUTICS, INC., CAMBRIDGE, MA, US
• Cullinan Oncology, Inc., Cambridge, MA, US

Prosecution history

• 10 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 10 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 10 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 20 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 20 May 2025 — REGISTERED-PRINCIPAL REGISTER
• 01 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 01 Apr 2025 — PUBLISHED FOR OPPOSITION
• 26 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 10 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 10 Mar 2025 — USE AMENDMENT ACCEPTED
• 06 Mar 2025 — AMENDMENT TO USE PROCESSING COMPLETE
• 06 Mar 2025 — USE AMENDMENT FILED
• 06 Mar 2025 — TEAS AMENDMENT OF USE RECEIVED
• 06 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 06 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE